PROVIDED BY:
“DEVELOPMENTAL PSYCHOPATHOLOGY:
A HELPFUL THEORY, A REAL SCIENCE”
DECEMBER 4, 2014 ~ 12:00 TO 1:00 PM
LOCATION:
BRB II/III AUDITORIUM
STEVEN J. BERKOWITZ, M.D.
ASSOCIATE PROFESSOR OF CLINICAL PSYCHIATRY
DIRECTOR, CENTER FOR YOUTH AND FAMILY TRAUMATIC STRESS RECOVERY
DEPARTMENT OF PSYCHIATRY
UNIVERSITY OF PENNSYLVANIA PERELMAN SCHOOL OF MEDICINE
TARGET AUDIENCE
This program has been designed for departmental/institutional faculty, fellows, residents, and medical students in the medical
specialties of psychiatry, psychology, radiology, and neurology.
SERIES EDUCATIONAL OBJECTIVES
After completing this activity, participants should be able to:
 Implement trauma informed care, cutting-edge treatment and how this can be embedded within mental health training,
education and undergraduate programs
 Integrate new ethical and professional standards for forensic psychiatry as they relate to work done in the criminal
justice system
 Advance clinical knowledge, enrich and expand psychotherapy skills with the goal of improving patient care
SESSION EDUCATIONAL OBJECTIVES
After completing this activity, participants should be able to:
 Discuss how the theory of Developmental Psychopathology helps explain the etiology of psychiatric syndromes
 Describe that the majority of psychiatric syndromes are lifespan related
 Explain how the theory anticipated and supports GxE Research findings
ACCREDITATION
The Perelman School of Medicine at the University of Pennsylvania is accredited by the Accreditation Council for Continuing Medical
Education (ACCME) to provide continuing medical education for physicians.
DESIGNATION OF CREDIT
The Perelman School of Medicine at the University of Pennsylvania designates this live activity for a maximum of 1 AMA PRA
Category 1 Credit ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ACKNOWLEDGEMENT OF COMMERCIAL SUPPORT*
NONE
For more information, please contact
NATALIE CONLIN
215-662-2899
NATALIEC@MAIL.MED.UPENN.EDU
Check your CME online at www.penncmeonline.com
DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS AND UNAPPROVED USES OF PRODUCTS
It is policy at the Perelman School of Medicine at the University of Pennsylvania for individuals who are in a position to control the
content of an educational activity to disclose to the learners all relevant financial relationships that they have with any commercial
interest that provides products or services that may be relevant to the content of this continuing medical education activity. For this
purpose we consider relationships of the person involved in the CME activity to include financial relationships of a spouse or partner.
The intent of this policy is not to prevent expert faculty with relevant relationship(s) with commercial interest(s) from involvement in
CME, but rather to ensure that Penn CME-certified activities promote quality and safety, are effective in improving medical practice,
are based on valid content, and are independent of control from commercial interests and free of commercial bias. Peer review of all
content was conducted for all faculty presentations whose disclosure information provided to the Penn Office of CME was found to
contain relationships that created a conflict of interest relative to the topic of their presentation. In addition, all faculty were
instructed to provide balanced, scientifically rigorous and evidence-based presentations.
The staff in the Office of CME at the Perelman School of Medicine at the University of Pennsylvania, Mila Kostic, Director of
CME and the peer reviewer Zalman Agus, MD, Associate Dean for CME, have disclosed that they have no relevant financial
relationships with any commercial interests related to the content of this educational activity.
The following individuals have disclosed that they have no relevant financial relationships with any commercial interests related to
the content of this educational activity:
PLANNING COMMITTEE MEMBER NAME
RAQUEL E. GUR, MD, PHD
PAUL F. CRITS-CHRISTOPH, PHD
PRESENTER NAME
STEVEN J. BERKOWITZ, M.D.
The following individuals have reported the listed relevant financial relationships with commercial interests related to the content of this educational activity.
PLANNING COMMITTEE MEMBER NAME
NAME OF COMMERCIAL INTEREST
RELATIONSHIP
C. NEILL EPPERSON, MD
ANTHONY ROSTAIN, MD, MA
MICHAEL THASE, MD
PRESENTER NAME
PFIZER, MERCK, ABBOTT, ABBVIE, JOHNSON & JOHNSON
SHIRE
BIOBEHAVIORAL DIAGNOSTICS/PEARSON, ALEOBRA
ROUTLEDGE/TAYLOR FRANCIS GROUP
ALKERMES, ASTRAZENECA, BRISTOL-MYERS SQUIBB, CERECOR, INC,
ELI LILLY & CO., DEY PHARMA, LLP, FOREST, GERSON LEHMAN GROUP,
GUIDEPOINT GLOBAL, H. LUNDBECK A/S, MEDAVANTE, MERCK AND CO, INC.,
NEURONETICS, INC, OTSUKA PHARMACEUTICALS, ORTH-MCNEIL PHARMA,
PAMLAB, PFIER, SHIRE, SUNOVION PHARMA, TAKEDA, TRANSCEPT PHARM
FOREST PHARMACEUTICALS, NATIONAL INSTITUTE OF MENTAL HEALTH,
OTSUKA PHARMACEUTICALS, PHARMANEUROBOOST, ROCHE
MEDAVANTE, INC.
AMERICAN PSYCHIATRIC FOUNDATION, GUILFORD PUBLICATIONS, HERALD HOUSE,
WW NORTON & CO, IN.
NAME OF COMMERCIAL INTEREST
INVESTMENTS
RESEARCH GRANT
ADVISORY BOARD
ROYALTIES
ADVISORY/CONSULTANT
GRANT SUPPORT
EQUITY HOLDINGS
ROYALTIES
RELATIONSHIP
Relevant Financial Relationships: Financial relationships are those relationships in which the individual benefits by receiving a salary,
royalty, intellectual property rights, consulting fee, honoraria, ownership interest (e.g., stocks, stock options or other ownership
interest, excluding diversified mutual funds), or other financial benefit. Financial benefits are usually associated with roles such as
employment, management position, independent contractor (including contracted research), consulting, speaking and teaching,
membership on advisory committees or review panels, board membership, and other activities from which remuneration is received
or expected.
DISCLOSURE OF UNAPPROVED USES OF PRODUCTS
PRESENTER NAME
PRODUCT
INVESTIGATIONAL AND/OR OFF-LABEL USE